The global Core Needle Biopsy Device market size will be USD 6854.5 million in 2024.

According to Cognitive Market Research, the global Core Needle Biopsy Device market size will be USD 6854.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 15.20% from 2024 to 2031.North America held the major market share for more than 40% of the global revenue with a market size of USD 2741.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.4% from 2024 to 2031.Europe accounted for a market share of over 30% of the global revenue with a market size of USD 2056.35 million.Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1576.54 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.2% from 2024 to 2031.Latin America had a market share of more than 5% of the global revenue with a market size of USD 342.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.6% from 2024 to 2031.Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 137.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.9% from 2024 to 2031.The direct sales emerge as the dominant distribution channel. This approach allows manufacturers to maintain close relationships with healthcare providers, ensuring a deeper understanding of their needs and preferences  Market Dynamics of Core Needle Biopsy Device MarketKey Drivers for Core Needle Biopsy Device MarketGrowing Incidence of Cancer to Boost Market GrowthOne of the primary drivers propelling the Core Needle Biopsy Device market is the escalating incidence of cancer worldwide. As cancer remains a leading cause of morbidity and mortality, early and accurate diagnosis is crucial for effective treatment planning. Core needle biopsy devices provide a minimally invasive option to obtain tissue samples for histopathological examination, facilitating timely and accurate diagnoses. This growing need for precise diagnostic tools is further amplified by advancements in imaging technologies, which enable better localization of lesions and enhance the accuracy of biopsy procedures. As healthcare providers prioritize early detection strategies, the demand for core needle biopsy devices is expected to surge, ultimately driving market growth.Technological Advancements in Biopsy Devices to Drive Market GrowthTechnological innovation stands as another significant driver in the Core Needle Biopsy Device market. Recent advancements, including the development of automated and image-guided biopsy systems, have revolutionized the biopsy procedure, improving both patient outcomes and procedural efficiency. Enhanced designs that minimize trauma, reduce bleeding risks, and allow for quicker recovery times are gaining traction among healthcare professionals and patients alike. Furthermore, the integration of robotic assistance and real-time imaging during biopsies has increased the accuracy of tissue sampling, thus reducing the likelihood of repeat procedures. As these sophisticated technologies become more prevalent in clinical settings, the core needle biopsy device market is poised for considerable growth, reflecting the healthcare industry's ongoing commitment to improving diagnostic capabilities.Restraint Factor for the Core Needle Biopsy Device MarketLimited Awareness and Training, will Limit Market GrowthA significant restraint in the Core Needle Biopsy Device market is the limited awareness and training among healthcare professionals regarding the use of these devices. Many practitioners may not be fully trained in the latest biopsy techniques, leading to hesitance in adopting new technologies. Additionally, variations in regional healthcare practices and protocols can result in inconsistent usage of core needle biopsy devices. This lack of familiarity not only affects the frequency of procedures performed but can also impact patient outcomes, ultimately hindering market growth as healthcare facilities may delay investing in advanced biopsy technologies.Impact of Covid-19 on the Core Needle Biopsy Device MarketThe COVID-19 pandemic has had a profound impact on the Core Needle Biopsy Device market, primarily disrupting routine healthcare services and elective procedures. During the height of the pandemic, many hospitals and clinics postponed non-emergency medical interventions, including biopsies, to allocate res...